Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats

Methotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats

Raul C Maranhão,1,2 Maria C Guido,1 Aline D de Lima,1 Elaine R Tavares,1 Alyne F Marques,1 Marcelo D Tavares de Melo,3 Jose C Nicolau,3 Vera MC Salemi,3 Roberto Kalil-Filho3 1Laboratory of Metabolism and Lipids, 2Faculty of Pharmaceutical Sciences, 3Heart Failure Unit, Clinical Cardiolog...

Full description

Bibliographic Details
Main Authors: Maranhão RC, Guido MC, de Lima AD, Tavares ER, Marques AF, Tavares de Melo MD, Nicolau JC, Salemi VMC, Kalil-Filho R
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:International Journal of Nanomedicine
Subjects:
lipid particle
drug delivery
adenosine
VEGF
myocardial infarction.
Online Access:https://www.dovepress.com/methotrexate-carried-in-lipid-core-nanoparticles-reduces-myocardial-in-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/methotrexate-carried-in-lipid-core-nanoparticles-reduces-myocardial-in-peer-reviewed-article-IJN

Similar Items